Key result
Diabetes linked to ~26% less lumen gain after coronary stenting versus non-diabetics.
Why the study?
Does the mechanism of lumen gain during coronary stent deployment differ between diabetic and non-diabetic patients?
Observational (n=123)
Does the mechanism of lumen gain during coronary stent deployment differ between diabetic and non-diabetic patients?
Diabetic patients achieve less lumen gain during coronary stenting due to impaired vessel wall stretching and less plaque reduction, highlighting a potential role for plaque modification prior to stenting.
Answers are grounded in this paper and cite their sources.
Diabetic patients may benefit from pre-stent plaque modification; this Level 3 finding leaves open whether lumen gain differences affect outcomes or warrant practice change.
BACKGROUND: Diabetic patients show an increased incidence of restenosis after coronary angioplasty than non-diabetic patients. This may be because of differences in the mechanism of lumen gain during coronary revascularization in this population cohort. DESIGN: This study analyses the mechanism of lumen gain during coronary stent deployment in diabetic patients compared with non-diabetic patients with intravascular ultrasound (IVUS). METHODS: IVUS images were obtained prior to and after revascularization in 26 diabetic and 97 non-diabetic patients. The external elastic membrane cross-sectional area (EEM) and lumen cross-sectional area (LA) were measured. Plaque area (PA) was calculated as EEM minus LA. Differences between pre- and post-LA (deltaLA), EEM (deltaEEM) and PA (deltaPA) were calculated. RESULTS: Pre-interventional PA (diabetic patients: 12.4 +/- 4.4 mm2 compared with non-diabetic patients: 10.7 +/- 3.6 mm2, = 0.04) and pre-interventional EEM (15.5 +/- 4.4 mm2 compared with 13.6 +/- 3.7 mm2 respectively, P = 0.02) were larger in the diabetic group. Postinterventional PA (10.2 +/- 3.2 mm2 compared with 8.0 +/- 3.4 mm2, P = 0.004) was also larger and postinterventional LA (6.3 +/- 2.2 mm2 compared with 7.4 +/- 2.4 mm2 = 0.04), deltaEEM (0.9 +/- 1.8 mm2 compared with 1.8 +/- 1.8 mm2 P = 0.04) and deltaLA (3.1 +/- 1.6 mm2 compared with 4.2 +/- 2.2 mm2, P = 0.03) were smaller in the diabetic group. The diabetic group exhibited longer lesion lengths (P = 0.04) and a higher inflation pressure was used during revascularization in this patient cohort (P = 0.02). CONCLUSION: Diabetic patients have less reduction of PA during revascularization and because the vessel wall cannot be stretched outwards despite higher inflation pressure, postinterventional LA remains smaller than in the non-diabetic population cohort. This might be a rudiment for consideration of different treatment strategies such as cutting balloon or atherectomy prior to stenting in this population group in order to achieve better procedural outcome.
No takes yet. Share an insight, caveat, or question.
Syeda et al. (2002) conducted an observational in Coronary artery disease requiring stent deployment (n=123). Diabetes mellitus vs. Non-diabetic patients was evaluated on Change in lumen cross-sectional area (deltaLA) (p=0.03). Diabetic patients undergoing coronary stenting achieved less lumen gain compared with non-diabetic patients.
Synapse has enriched 10 related papers. Consider them for comparative context: